N Balato

43PUBLICATIONS
173CO-AUTHORS
Molecular targetsAllergyAdolescent healthEpidemiological methodsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Aug 05, 2026
Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study.

|Jul 22, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

|May 14, 2026
Treatment-associated phenotype switching between psoriasis and atopic dermatitis.

|Apr 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).

Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya

|Feb 11, 2026
Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real-World Experience.

Paolino Franzese, Anna Balato, Eugenia Veronica Di Brizzi

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

Pageof 8

Frequent Collaborators

8 joint publications

Paolo Gisondi

7 joint publications

Matteo Megna

7 joint publications

Angelo Valerio Marzano

7 joint publications

Maria Concetta Fargnoli